Search - tctmd.com

Displaying 181 - 200 of 310

Sort: Relevancy | Date

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

Aortic Root Pseudo-aneurysm Repair With Evolut-R CoreValve

Presenter: Shigeru Saito, Jonathon M. White, Brett Hiendlmayr, MD

June 16, 2017

Presentation TVT 2017

Severe PVL, Caused by Ventricular Migration of Evolut R, Successfully Treated With Sapien-3 Valve-in-Valve

Presenter: David W.M. Muller, Lars Sondergaard, Peter den Heijer, MD

June 16, 2017

Presentation TVT 2017

Evolut R Snapshots II Techniques to Minimize PPM

Presenter: Ariel Finkelstein

June 16, 2017

Presentation TVT 2017

Evolut R Snapshots I - The New Evolut R PRO System

Presenter: John K. Forrest

June 16, 2017

Presentation TVT 2017

The Evolut R TAVR System: A Cool Case, New Technology (Including 34mm), and Clinical Program Updates

Presenter: Jeffrey J. Popma

June 16, 2017

Presentation TVT 2017

TAVR for Pure Aortic Insufficiency (AI) With Prior Ascending Aortic Hemi-shield Repair : Unique Role for EVOLUT-R

Presenter: Albert Markus Kasel, Thomas Walther, Soundos Moualla, MD

June 15, 2017

Presentation TVT 2017

Expert Commentary: Evolut R in Degenerative Surgical Aortic Bioprostheses (VIVA Registry)

Presenter: Ran Kornowski

June 15, 2017

Presentation TVT 2017

TAVR in Perspective Evolution, Impact, and Future Expectations

Presenter: Mark Reisman, Gregg W. Stone, Martin B. Leon

June 15, 2017

Presentation TVT 2017

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow

June 15, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

Shelley Wood

May 18, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Shelley Wood

May 16, 2017

News Industry News

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

May 15, 2017

News Daily News

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

Caitlin E. Cox

April 21, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Shelley Wood

March 24, 2017

Advertisement

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Aortic Root Pseudo-aneurysm Repair With Evolut-R CoreValve

Severe PVL, Caused by Ventricular Migration of Evolut R, Successfully Treated With Sapien-3 Valve-in-Valve

Evolut R Snapshots II Techniques to Minimize PPM

Evolut R Snapshots I - The New Evolut R PRO System

The Evolut R TAVR System: A Cool Case, New Technology (Including 34mm), and Clinical Program Updates

TAVR for Pure Aortic Insufficiency (AI) With Prior Ascending Aortic Hemi-shield Repair : Unique Role for EVOLUT-R

Expert Commentary: Evolut R in Degenerative Surgical Aortic Bioprostheses (VIVA Registry)

TAVR in Perspective Evolution, Impact, and Future Expectations

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

More Early Stroke With SAVR Than TAVR in SURTAVI

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content